ConductScience.org, home

Paper22140652

Characterization of KRAS rearrangements in metastatic prostate cancer.

Wang XS and 25 others. Cancer Discov, 2011. Cited by 87 papers, by iCite.

Cite this record

ConductScience Library. Characterization of KRAS rearrangements in metastatic prostate cancer. Papers, record 22140652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22140652

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Characterization of KRAS rearrangements in metastatic prostate cancer.
PubMed
Journal
Cancer Discov
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
87
iCite
Relative citation ratio, by iCite
1.64
iCite
Revised in PubMed
2025-05-29
PubMed

Authors26

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang XSXiao-Song
2Shankar SSunita
3Dhanasekaran SMSaravana M
4Ateeq BBushra
5Sasaki ATAtsuo T
6Jing XXiaojun
7Robinson DDaniel
8Cao QQi
9Prensner JRJohn R
10Yocum AKAnastasia K
11Wang RRui
12Fries DFDaniel F
13Han BBo
14Asangani IAIrfan A
15Cao XXuhong
16Li YYong
17Omenn GSGilbert S
18Pflueger DDorothee
19Gopalan AAnuradha
20Reuter VEVictor E

Source PubMed

See all 26 authorsDownload CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gene RearrangementMajor topic
Prostatic NeoplasmsMajor topic
Proto-Oncogene ProteinsMajor topic
Proto-Oncogene Proteins p21(ras)Major topic
ras ProteinsMajor topic
Animals
Cell Line, Tumor
Extracellular Signal-Regulated MAP Kinases
Gene Fusion
HEK293 Cells
Humans
MAP Kinase Kinase Kinases
Male
Mice
Mutation
NIH 3T3 Cells
Proto-Oncogene Proteins c-akt
Ubiquitin-Conjugating Enzymes
p38 Mitogen-Activated Protein Kinases

Source PubMed

Download CSV of topics

Grants12

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
U54 DA21519-01A1NIDA NIH HHSUnited StatesU54DA215190PubMedNIH RePORTER
UO1 CA111275NCI NIH HHSUnited StatesU01CA111275PubMed and NIHNIH RePORTER
R01 CA125612-01NCI NIH HHSUnited StatesR01CA125612PubMed and NIHNIH RePORTER
R01 CA132874NCI NIH HHSUnited StatesR01CA132874PubMed and NIHNIH RePORTER
P50CA69568NCI NIH HHSUnited StatesP50CA069568PubMed and NIHNIH RePORTER
R01 CA125612NCI NIH HHSUnited StatesR01CA125612PubMed and NIHNIH RePORTER
P01 CA089021NCI NIH HHSUnited StatesP01CA089021PubMed and NIHNIH RePORTER
R01CA132874NCI NIH HHSUnited StatesR01CA132874PubMed and NIHNIH RePORTER
U54 DA021519NIDA NIH HHSUnited StatesU54DA021519PubMed and NIHNIH RePORTER
P50 CA069568NCI NIH HHSUnited StatesP50CA069568PubMed and NIHNIH RePORTER
U01 CA111275NCI NIH HHSUnited StatesU01CA111275PubMed and NIHNIH RePORTER
R01 GM056203NIGMS NIH HHSUnited StatesR01GM056203PubMed and NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in22586312KRAS oncogene rearrangements and gene fusions: unexpected rare encounters in late-stage prostate cancers.https://conductscience.org/library/papers/22586312

Source PubMed

Download CSV of comments and corrections

References23

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19693040Fine-mapping, genomic organization, and transcript analysis of the human ubiquitin-conjugating enzyme gene UBE2L3.Genomics1998https://conductscience.org/library/papers/9693040PubMed
216015385Fusion of NUP214 to ABL1 on amplified episomes in T-ALL--implications for treatment.Leukemia2005https://conductscience.org/library/papers/16015385PubMed
320526349Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma.Nat Med2010https://conductscience.org/library/papers/20526349PubMed
418594010EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer.Clin Cancer Res2008https://conductscience.org/library/papers/18594010PubMed
515475419Circular binary segmentation for the analysis of array-based DNA copy number data.Biostatistics2004https://conductscience.org/library/papers/15475419PubMed
615210703Transformation potential of Ras isoforms correlates with activation of phosphatidylinositol 3-kinase but not ERK.J Biol Chem2004https://conductscience.org/library/papers/15210703PubMed
710827191Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression.J Biol Chem2000https://conductscience.org/library/papers/10827191PubMed
86285355Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses.Proc Natl Acad Sci U S A1982https://conductscience.org/library/papers/6285355PubMed
919008416Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer.Science2008https://conductscience.org/library/papers/19008416PubMed
108789435In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcoma.Hum Mol Genet1996https://conductscience.org/library/papers/8789435PubMed
1118408710BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.Nature2008https://conductscience.org/library/papers/18408710PubMed
127769849Extensive amplification of bcr/abl fusion genes clustered on three marker chromosomes in human leukemic cell line K-562.Leukemia1995https://conductscience.org/library/papers/7769849PubMed
1314500907EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells.Proc Natl Acad Sci U S A2003https://conductscience.org/library/papers/14500907PubMed
1416869784Cancer targets in the Ras pathway.Cold Spring Harb Symp Quant Biol2005https://conductscience.org/library/papers/16869784PubMed
1518568040Ras oncogenes: split personalities.Nat Rev Mol Cell Biol2008https://conductscience.org/library/papers/18568040PubMed
161608859Infrequent RAS oncogene mutations in human prostate cancer.Prostate1992https://conductscience.org/library/papers/1608859PubMed
1715361874Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia.Nat Genet2004https://conductscience.org/library/papers/15361874PubMed
1817952124Array CGH and gene-expression profiling reveals distinct genomic instability patterns associated with DNA repair and cell-cycle checkpoint pathways in Ewing's sarcoma.Oncogene2008https://conductscience.org/library/papers/17952124PubMed
1917384584Hyperactive Ras in developmental disorders and cancer.Nat Rev Cancer2007https://conductscience.org/library/papers/17384584PubMed
2016407830MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer.Oncogene2006https://conductscience.org/library/papers/16407830PubMed

See all 23 referencesDownload CSV of references

Cited by65

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.

PMIDTitleJournalYearIn PapersSource
42564652Pleomorphic Giant Cell Carcinoma of the Prostate Treated With Lutetium-177 PSMA.Case Rep Urol2026https://conductscience.org/library/papers/42564652PubMed
42129337Decoding the Raf-Mek-Erk-Rsk pathway in prostate cancer: from molecular mechanisms to clinical opportunities.Br J Cancer2026https://conductscience.org/library/papers/42129337PubMed
42100391Mechanistic insights and molecular therapy for neuroendocrine prostate cancer.Front Oncol2026https://conductscience.org/library/papers/42100391PubMed
42069672Fibroblast-mediated KRAS activation in double-negative prostate cancer.Cell Death Dis2026https://conductscience.org/library/papers/42069672PubMed
41309533Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges.Signal Transduct Target Ther2025https://conductscience.org/library/papers/41309533PubMed
40331986Network Pharmacology and Molecular Dynamics Identified Potential Androgen Receptor-Targeted Metabolites in Crocus alatavicus.Int J Mol Sci2025https://conductscience.org/library/papers/40331986PubMed
40063516Emerin Dysregulation Drives the Very-Small-Nuclear Phenotype and Lineage Plasticity That Associate with a Clinically Aggressive Subtype of Prostate Cancer.Clin Cancer Res2025https://conductscience.org/library/papers/40063516PubMed
39895829Systematic Analysis of E3 Ligase-Related Genes Identified UBE2L3 as a Prognostic Biomarker Associated With Drug Resistance in Acute Myeloid Leukemia.Int J Gen Med2025https://conductscience.org/library/papers/39895829PubMed
38345532Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived Xenografts.Mol Cancer Res2024https://conductscience.org/library/papers/38345532PubMed
38339274Molecular Mechanisms of Prostate Cancer Development in the Precision Medicine Era: A Comprehensive Review.Cancers (Basel)2024https://conductscience.org/library/papers/38339274PubMed
35598018Multiple metastases of androgen indifferent prostate cancer in the urinary tract: two case reports and a literature review.BMC Med Genomics2022https://conductscience.org/library/papers/35598018PubMed
35265070Mechanism and Disease Association With a Ubiquitin Conjugating E2 Enzyme: UBE2L3.Front Immunol2022https://conductscience.org/library/papers/35265070PubMed
35198441Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells.Front Oncol2022https://conductscience.org/library/papers/35198441PubMed
35117547Overview of research on fusion genes in prostate cancer.Transl Cancer Res2020https://conductscience.org/library/papers/35117547PubMed
34095988The impact of fusion genes on cancer stem cells and drug resistance.Mol Cell Biochem2021https://conductscience.org/library/papers/34095988PubMed
33801965Targeting KRAS in Cancer: Promising Therapeutic Strategies.Cancers (Basel)2021https://conductscience.org/library/papers/33801965PubMed
33718092Downregulation of PARVA promotes metastasis by modulating integrin-linked kinase activity and regulating MAPK/ERK and MLC2 signaling in prostate cancer.Transl Androl Urol2021https://conductscience.org/library/papers/33718092PubMed
32444378Synthesis of the PET Tracer 124I-Trametinib for MAPK/ERK Kinase Distribution and Resistance Monitoring.J Nucl Med2020https://conductscience.org/library/papers/32444378PubMed
32397189Pathway Analysis of Genes Identified through Post-GWAS to Underpin Prostate Cancer Aetiology.Genes (Basel)2020https://conductscience.org/library/papers/32397189PubMed
32321829Landscape analysis of adjacent gene rearrangements reveals BCL2L14-ETV6 gene fusions in more aggressive triple-negative breast cancer.Proc Natl Acad Sci U S A2020https://conductscience.org/library/papers/32321829PubMed

See all 65 cited byDownload CSV of cited by

Genes16

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22140652

GET https://conductscience.org/api/papers/v1/22140652/authors?page=2